Quick Answer
ALBEMARLE CORP reported Cash and Equivalents of $613.11 million for fiscal year 2019.
ALBEMARLE CORP Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2019 | $613.11M | +10.4% |
| 2018 | $555.32M | -51.2% |
| 2017 | $1.14B | -49.9% |
| 2016 | $2.27B | +962.0% |
| 2015 | $213.73M | -91.4% |
| 2014 | $2.49B | +421.7% |
| 2013 | $477.24M | -0.1% |
| 2012 | $477.70M | +1.8% |
| 2011 | $469.42M | -11.4% |
| 2010 | $529.65M | +71.5% |
| 2009 | $308.79M | +21.9% |
| 2008 | $253.30M | +94.0% |
| 2007 | $130.55M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.93B | +16.1% | +6.9% |
| June 30, 2025 | $1.81B | -1.3% | +19.0% |
| March 31, 2025 | $1.52B | -26.1% | +27.4% |
| December 31, 2024 | $1.19B | +34.0% | -28.4% |
| September 30, 2024 | $1.66B | +3.9% | -9.1% |
| June 30, 2024 | $1.83B | +14.4% | -11.0% |
| March 31, 2024 | $2.06B | +29.6% | +131.0% |
| December 31, 2023 | $889.90M | -40.6% | -44.4% |
- ALBEMARLE CORP showed an increase of +10.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2019 period, ALBEMARLE CORP’s cash and equivalents has grown by 369.6% (from $130.55 million to $613.11 million).
- The most recent figure is from ALBEMARLE CORP’s fiscal year 2019 report (Form 10-K), filed with the SEC on February 26, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: